Peritoneal Dialysis Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offerings, Dialysis Type, Indication, End User, and Geography

Description

List of Tables

According to our new research study on "Peritoneal Dialysis Market Forecast to 2034 Global Analysis - by product, material, end user and Geography," the market is anticipated to grow from US$ 11.56 billion in 2025 and is projected to reach US$ 21.55 billion by 2034; it is expected to register a CAGR of 7.2% during 2026-2034. The peritoneal dialysis market growth has anticipated owing to expansion of ESRD treatment pool with limited transplant penetration as well as reimbursement design favoring home dialysis economics.

The peritoneal dialysis market is experiencing a pronounced structural shift in terms of modality preferences taking place in the peritoneal dialysis market in favor of moving away from the utilization of CAPD to APD. This change indicates a growing evolution of the business model within renal therapy provision that involves the importance of factors such as efficiency and convenience in making decisions about renal therapy choice. The introduction of APD into the market is significantly changing its economics through the creation of a high-value proposition, whereby the use of the automated system leads to higher per-patient revenue than the traditional manual exchange procedure utilized in CAPD therapy. APD involves the utilization of dedicated dialysis machines that work alongside consumable items such as tubing, while CAPD uses only consumable products.

Apart from the commercial benefits that have made it popular, APD has become increasingly favored for its advantages that range from clinical aspects to lifestyle adjustments, including the ability to undertake dialysis at night time. With such a way of conducting dialysis treatment, there will be fewer interruptions during the day when the patient can go about their regular activities, leading to greater adherence to treatment among other things. In addition to this, APD has allowed a broader population of patients to undertake treatment in addition to CAPD patients, which include employees who need to minimize their involvement in workplace activities as well as senior citizens who would benefit from automated dialysis cycles which will reduce their manual engagement with the equipment. There have been health systems interventions in favor of treatment adherence which have played an important role in making this treatment modality popular.

There is currently restructuring being carried out in healthcare systems where the focus has shifted towards de-centralized chronic disease care due to constant pressure on in-patient facilities coupled with increased workloads as well as the need to become more economical along the line of lengthy care processes. In this respect, care management in the renal domain has come to the forefront.

Peritoneal dialysis is becoming more relevant for the implementation of the decentralization agenda through the provision of peritoneal dialysis treatment. This treatment method is capable of shifting the treatment processes from the clinic setting to home care without compromising the clinical continuity and effectiveness of procedures performed. Peritoneal dialysis is highly applicable in situations where dialysis centers face constant saturation due to an increase in the demand for the services of clinics and staff, and extending their capacities is not feasible in terms of both performance and economics. Thus, through peritoneal dialysis treatments, patients can be provided with an opportunity to manage themselves and avoid overcrowding of hospitals and, therefore, improve the efficiency of the system. Peritoneal dialysis can have a twofold impact on the health system efficiency. First, this technique contributes to the better use of hospital facilities since low-intensity cases will no longer require such resources. On the other hand, peritoneal dialysis can help redefine the system of medical care delivery as dialysis management becomes integrated into patient-centered care with occasional supervision performed by the provider organization.

Key insights and analytical perspectives on the global peritoneal dialysis market are derived from a broad ecosystem of renal care regulatory authorities, clinical governance bodies, and nephrology-focused research organizations that collectively shape treatment standards, safety protocols, and reimbursement frameworks. Core regulatory oversight is provided by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), which govern approval pathways for dialysis devices, solutions, and associated medical technologies, including peritoneal dialysis cyclers, catheter systems, and biocompatible dialysate formulations. In parallel, international standardization frameworks such as the International Organization for Standardization (ISO) establish quality and safety benchmarks for dialysis fluids, equipment manufacturing, and infection control protocols, ensuring consistency across global supply chains.

Product Code: TIPMD00002583

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. Peritoneal Dialysis Market Landscape

2.1 Overview
2.2 Value Chain Analysis
- 2.2.1 Raw Materials/Components
- 2.2.2 Manufacturing Process/Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End-User
- 2.2.5 Level of Integration
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Force Analysis
2.5 PEST Analysis
2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
2.7 Impact of Artificial Intelligence (AI)
2.8 Product or Technology Roadmap
2.9 Sustainability and ESG Trends
2.10 Patent Analysis
2.11 Regulatory Framework
2.12 Key Success Factors
2.13 Top Investment Pockets
2.14 PESTEL Analysis
2.15 Installed Analysis
2.16 Case Study Analysis
2.17 Pricing Analysis
2.18 Ecosystem Analysis
2.19 Reimbursement Analysis
2.20 Epidemiology Analysis
2.21 Peritoneal Dialysis Volume Analysis
2.22 Adoption Rate and Number of Patients on PD, By Country - 2021, 2025, and 2032

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration
3.4 Top 5 Player Comparison
3.5 Strategies Adopted by Key Market Players
3.6 Recent Developments in the Market

4. Peritoneal Dialysis Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints

5. Peritoneal Dialysis Market - Global Market Analysis

5.1 Peritoneal Dialysis Market Revenue (US$ Million), 2021-2034
5.2 Peritoneal Dialysis Market Forecast and Analysis

6. Peritoneal Dialysis Market Revenue Analysis - Offerings

6.1 Peritoneal Dialysis Market Forecasts and Analysis by Offerings
6.2 Product
- 6.2.1 Overview
- 6.2.2 Product Market Revenue, 2021-2034 (US$ Million)
- 6.2.3 Product Breakdown - (Dialysis Machines, Dialysis Bags [Dialysate Solution Bag {Glucose-Based Dialysate Bags[Glucose 1.5%, Glucose 2.5%, Glucose 4.25%], Icodextrin-Based Dialysate Bags, Amino Acid-Based Dialysate Bags, Bicarbonate-Based Dialysate Bags}, Drainage Bag, Twin Bag], Catheters, Transfer Set, Others)
6.3 Services
- 6.3.1 Overview
- 6.3.2 Services Market Revenue, 2021-2034 (US$ Million)

7. Peritoneal Dialysis Market Revenue Analysis - Dialysis Type

7.1 Peritoneal Dialysis Market Forecasts and Analysis by Dialysis Type
7.2 Continuous Ambulatory Peritoneal Dialysis (CAPD)
- 7.2.1 Overview
- 7.2.2 Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Revenue, 2021-2034 (US$ Million)
7.3 Automated Peritoneal Dialysis (APD)
- 7.3.1 Overview
- 7.3.2 Automated Peritoneal Dialysis (APD) Market Revenue, 2021-2034 (US$ Million)

8. Peritoneal Dialysis Market Revenue Analysis - Indication

8.1 Peritoneal Dialysis Market Forecasts and Analysis by Indication
8.2 End-Stage Renal Disease (ESRD)
- 8.2.1 Overview
- 8.2.2 End-Stage Renal Disease (ESRD) Market Revenue, 2021-2034 (US$ Million)
8.3 Acute Kidney Injury
- 8.3.1 Overview
- 8.3.2 Acute Kidney Injury Market Revenue, 2021-2034 (US$ Million)
8.4 Chronic Kidney Disease
- 8.4.1 Overview
- 8.4.2 Chronic Kidney Disease Market Revenue, 2021-2034 (US$ Million)

9. Peritoneal Dialysis Market Revenue Analysis - End User

9.1 Peritoneal Dialysis Market Forecasts and Analysis by End User
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals Market Revenue, 2021-2034 (US$ Million)
9.3 Dialysis Centers and Clinics
- 9.3.1 Overview
- 9.3.2 Dialysis Centers and Clinics Market Revenue, 2021-2034 (US$ Million)
9.4 Homecare Settings
- 9.4.1 Overview
- 9.4.2 Homecare Settings Market Revenue, 2021-2034 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others Market Revenue, 2021-2034 (US$ Million)

10. Peritoneal Dialysis Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Peritoneal Dialysis Market Overview
- 10.1.2 North America: Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.3 North America: Peritoneal Dialysis Market - By Segmentation
  - 10.1.3.1 Offerings
  - 10.1.3.2 Dialysis Type
  - 10.1.3.3 Indication
  - 10.1.3.4 End User
- 10.1.4 North America: Peritoneal Dialysis Market Breakdown by Countries
  - 10.1.4.1 United States Market
    - 10.1.4.1.1 United States: Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 10.1.4.1.2 United States: Peritoneal Dialysis Market - By Segmentation
      - 10.1.4.1.2.1 Offerings
      - 10.1.4.1.2.2 Dialysis Type
      - 10.1.4.1.2.3 Indication
      - 10.1.4.1.2.4 End User
  - 10.1.4.2 Canada Market
  - 10.1.4.3 Mexico Market
10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Russia
- 10.2.7 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Thailand
  - 10.3.6.1 Adoption rate of PD, By key 8 Provinces
  - 10.3.6.2 Number of Patients on PD, By key 8 Provinces
  - 10.3.6.3 Number of Patients on Automated PD, By key 8 Provinces
- 10.3.7 Hong Kong
- 10.3.8 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 GCC Countries
- 10.4.3 Rest of Middle East and Africa
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Colombia
- 10.5.4 Mexico
  - 10.5.4.1 Adoption rate of PD, By key 8 Provinces
  - 10.5.4.2 Number of Patients on PD, By key 8 Provinces
  - 10.5.4.3 Number of Patients on Automated PD, By key 8 Provinces
- 10.5.5 Rest of Latin America

11. Peritoneal Dialysis Market Industry Landscape

12. Peritoneal Dialysis Market - Key Company Profiles

12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Vantive (formerly Baxter Kidney Care)
12.3 Fresenius Medical Care AG
12.4 B. Braun SE
12.5 Nipro Corp.
12.6 Nikkiso Co., Ltd
12.7 AsahiKaseiMedicalCo.,Ltd
12.8 DaVita Healthcare Partners
12.9 Kawasumi Laboratories
12.10 Bioteque Corporation
12.11 Becton Dickinson and Co
12.12 Newsol Technologies Inc
12.13 Poly Medicure Ltd
12.14 Utah Medical Products, Inc
12.15 Cook Medical Inc
12.16 Awak Technologies
12.17 Renax Biomedical Tech. Co. Ltd
12.18 Terumo Corporation
12.19 Huaren Pharmaceutical
12.20 Diaverum AB

13. List of Additional Companies Analyzed

14. China's Top Company Profiles

14.1 Renax Biomedical Tech. Co., Ltd.
14.2 Huaren Pharmaceutical
14.3 Beijing DC-Pharma
14.4 Shijiazhuang No. 4 Pharmaceutical Co., Ltd.,
14.5 Changzhou CareU Medical Instruments Co., Ltd.,
14.6 Guangzhou MeCan Medical Limited
14.7 Shanghai IVEN Pharmatech Engineering Co., Ltd.,

15. Appendix

15.1 Glossary
15.2 Research Methodology and Approach
- 15.2.1 Secondary Research
- 15.2.2 Primary Research
- 15.2.3 Market Estimation Approach
  - 15.2.3.1 Supply Side Analysis
  - 15.2.3.2 Demand Side Analysis
- 15.2.4 Research Assumptions and Limitations
15.3 Meet Our Analysts
15.4 About The Insight Partners
15.5 Market Intelligence Cloud